nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—THRB—breast cancer	0.203	0.518	CbGaD
Levothyroxine—SLC7A5—Melphalan—breast cancer	0.164	0.417	CbGbCtD
Levothyroxine—SLCO1B1—breast cancer	0.119	0.304	CbGaD
Levothyroxine—CYP3A4—breast cancer	0.0259	0.0661	CbGaD
Levothyroxine—SLCO1A2—Chlorambucil—breast cancer	0.0248	0.063	CbGbCtD
Levothyroxine—ALB—breast cancer	0.0226	0.0576	CbGaD
Levothyroxine—ABCB1—breast cancer	0.0215	0.055	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—breast cancer	0.0184	0.0466	CbGbCtD
Levothyroxine—SLCO1B3—Paclitaxel—breast cancer	0.0138	0.035	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—breast cancer	0.0129	0.0328	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—breast cancer	0.00998	0.0253	CbGbCtD
Levothyroxine—CYP2C8—Lapatinib—breast cancer	0.00873	0.0222	CbGbCtD
Levothyroxine—ABCB1—Toremifene—breast cancer	0.0081	0.0206	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—breast cancer	0.00793	0.0201	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—breast cancer	0.00721	0.0183	CbGbCtD
Levothyroxine—CYP3A4—Exemestane—breast cancer	0.007	0.0178	CbGbCtD
Levothyroxine—CYP2C8—Raloxifene—breast cancer	0.00662	0.0168	CbGbCtD
Levothyroxine—CYP3A4—Letrozole—breast cancer	0.00595	0.0151	CbGbCtD
Levothyroxine—ABCB1—Lapatinib—breast cancer	0.00591	0.015	CbGbCtD
Levothyroxine—CYP3A4—Anastrozole—breast cancer	0.00531	0.0135	CbGbCtD
Levothyroxine—CYP3A4—Toremifene—breast cancer	0.00485	0.0123	CbGbCtD
Levothyroxine—CYP3A4—Fulvestrant—breast cancer	0.00451	0.0114	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—breast cancer	0.00445	0.0113	CbGbCtD
Levothyroxine—CYP2C8—Tamoxifen—breast cancer	0.00437	0.0111	CbGbCtD
Levothyroxine—ALB—Irinotecan—breast cancer	0.00434	0.011	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—breast cancer	0.0042	0.0107	CbGbCtD
Levothyroxine—ALB—Fluorouracil—breast cancer	0.00417	0.0106	CbGbCtD
Levothyroxine—CYP3A4—Thiotepa—breast cancer	0.00402	0.0102	CbGbCtD
Levothyroxine—CYP3A4—Ixabepilone—breast cancer	0.00368	0.00933	CbGbCtD
Levothyroxine—CYP3A4—Lapatinib—breast cancer	0.00354	0.00898	CbGbCtD
Levothyroxine—CYP2C8—Paclitaxel—breast cancer	0.0034	0.00863	CbGbCtD
Levothyroxine—ABCB1—Vinorelbine—breast cancer	0.00328	0.00832	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—breast cancer	0.00322	0.00817	CbGbCtD
Levothyroxine—ABCB1—Tamoxifen—breast cancer	0.00296	0.00751	CbGbCtD
Levothyroxine—ABCB1—Mitoxantrone—breast cancer	0.00289	0.00732	CbGbCtD
Levothyroxine—CYP3A4—Raloxifene—breast cancer	0.00268	0.00681	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—breast cancer	0.00255	0.00647	CbGbCtD
Levothyroxine—ABCB1—Paclitaxel—breast cancer	0.0023	0.00584	CbGbCtD
Levothyroxine—ALB—Methotrexate—breast cancer	0.0023	0.00583	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—breast cancer	0.00227	0.00577	CbGbCtD
Levothyroxine—ABCB1—Vinblastine—breast cancer	0.00202	0.00513	CbGbCtD
Levothyroxine—CYP3A4—Vinorelbine—breast cancer	0.00196	0.00498	CbGbCtD
Levothyroxine—CYP3A4—Tamoxifen—breast cancer	0.00177	0.0045	CbGbCtD
Levothyroxine—CYP3A4—Mitoxantrone—breast cancer	0.00173	0.00439	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—breast cancer	0.00167	0.00423	CbGbCtD
Levothyroxine—CYP3A4—Paclitaxel—breast cancer	0.00138	0.0035	CbGbCtD
Levothyroxine—THRB—mammary gland—breast cancer	0.00137	0.0358	CbGeAlD
Levothyroxine—CYP3A4—Irinotecan—breast cancer	0.00136	0.00345	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—breast cancer	0.00124	0.00315	CbGbCtD
Levothyroxine—CYP3A4—Vinblastine—breast cancer	0.00121	0.00307	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—breast cancer	0.0012	0.00305	CbGbCtD
Levothyroxine—SLCO4C1—nipple—breast cancer	0.00118	0.0309	CbGeAlD
Levothyroxine—SLC7A5—mammary gland—breast cancer	0.00104	0.0273	CbGeAlD
Levothyroxine—CYP3A4—Docetaxel—breast cancer	0.000998	0.00253	CbGbCtD
Levothyroxine—Dextrothyroxine—THRB—breast cancer	0.000958	0.257	CrCbGaD
Levothyroxine—SLCO4A1—mammary gland—breast cancer	0.000912	0.0239	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—breast cancer	0.000865	0.0227	CbGeAlD
Levothyroxine—SLC7A5—nipple—breast cancer	0.000864	0.0226	CbGeAlD
Levothyroxine—SLCO1B1—mammary gland—breast cancer	0.000802	0.021	CbGeAlD
Levothyroxine—SLC7A5—Desoximetasone—Fluoxymesterone—breast cancer	0.000793	1	CbGdCrCtD
Levothyroxine—SERPINA7—endocrine gland—breast cancer	0.000776	0.0203	CbGeAlD
Levothyroxine—SLCO4A1—nipple—breast cancer	0.000754	0.0198	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—breast cancer	0.000744	0.00189	CbGbCtD
Levothyroxine—SLCO4C1—endometrium—breast cancer	0.000713	0.0187	CbGeAlD
Levothyroxine—Liotrix—THRB—breast cancer	0.000709	0.19	CrCbGaD
Levothyroxine—TTR—embryo—breast cancer	0.000694	0.0182	CbGeAlD
Levothyroxine—ALB—mammary gland—breast cancer	0.000649	0.017	CbGeAlD
Levothyroxine—SLCO1B3—pituitary gland—breast cancer	0.000627	0.0164	CbGeAlD
Levothyroxine—SLC16A2—endometrium—breast cancer	0.000619	0.0162	CbGeAlD
Levothyroxine—THRB—pituitary gland—breast cancer	0.000619	0.0162	CbGeAlD
Levothyroxine—THRB—adipose tissue—breast cancer	0.000616	0.0161	CbGeAlD
Levothyroxine—THRA—adipose tissue—breast cancer	0.000616	0.0161	CbGeAlD
Levothyroxine—SLC7A5—epithelium—breast cancer	0.000582	0.0152	CbGeAlD
Levothyroxine—SLC16A2—uterus—breast cancer	0.000571	0.0149	CbGeAlD
Levothyroxine—THRB—female reproductive system—breast cancer	0.000566	0.0148	CbGeAlD
Levothyroxine—THRA—female reproductive system—breast cancer	0.000566	0.0148	CbGeAlD
Levothyroxine—Dextrothyroxine—SLCO1B1—breast cancer	0.000562	0.151	CrCbGaD
Levothyroxine—SLC16A2—pituitary gland—breast cancer	0.00056	0.0147	CbGeAlD
Levothyroxine—SLC16A2—adipose tissue—breast cancer	0.000558	0.0146	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—breast cancer	0.000558	0.0146	CbGeAlD
Levothyroxine—SLC7A5—skin of body—breast cancer	0.000553	0.0145	CbGeAlD
Levothyroxine—THRB—adrenal gland—breast cancer	0.000553	0.0145	CbGeAlD
Levothyroxine—THRA—adrenal gland—breast cancer	0.000553	0.0145	CbGeAlD
Levothyroxine—SLC7A5—endometrium—breast cancer	0.000522	0.0137	CbGeAlD
Levothyroxine—Liothyronine—THRB—breast cancer	0.000517	0.139	CrCbGaD
Levothyroxine—THRB—female gonad—breast cancer	0.000515	0.0135	CbGeAlD
Levothyroxine—THRA—female gonad—breast cancer	0.000515	0.0135	CbGeAlD
Levothyroxine—SLCO1C1—pituitary gland—breast cancer	0.000514	0.0135	CbGeAlD
Levothyroxine—SLCO1C1—adipose tissue—breast cancer	0.000512	0.0134	CbGeAlD
Levothyroxine—SLC16A2—adrenal gland—breast cancer	0.000501	0.0131	CbGeAlD
Levothyroxine—SLCO1B3—endocrine gland—breast cancer	0.000486	0.0127	CbGeAlD
Levothyroxine—SLC7A5—uterus—breast cancer	0.000481	0.0126	CbGeAlD
Levothyroxine—THRA—endocrine gland—breast cancer	0.000479	0.0125	CbGeAlD
Levothyroxine—THRB—endocrine gland—breast cancer	0.000479	0.0125	CbGeAlD
Levothyroxine—SLC7A5—pituitary gland—breast cancer	0.000472	0.0124	CbGeAlD
Levothyroxine—SLC7A5—adipose tissue—breast cancer	0.00047	0.0123	CbGeAlD
Levothyroxine—SLC16A2—female gonad—breast cancer	0.000467	0.0122	CbGeAlD
Levothyroxine—TTR—pituitary gland—breast cancer	0.00046	0.012	CbGeAlD
Levothyroxine—CYP2C8—mammary gland—breast cancer	0.000456	0.0119	CbGeAlD
Levothyroxine—SLCO4A1—endometrium—breast cancer	0.000455	0.0119	CbGeAlD
Levothyroxine—SLC16A2—endocrine gland—breast cancer	0.000434	0.0114	CbGeAlD
Levothyroxine—SLC7A5—female reproductive system—breast cancer	0.000432	0.0113	CbGeAlD
Levothyroxine—SLC7A5—adrenal gland—breast cancer	0.000422	0.011	CbGeAlD
Levothyroxine—TTR—female reproductive system—breast cancer	0.000421	0.011	CbGeAlD
Levothyroxine—Liotrix—SLCO1B1—breast cancer	0.000416	0.111	CrCbGaD
Levothyroxine—SLCO4A1—pituitary gland—breast cancer	0.000412	0.0108	CbGeAlD
Levothyroxine—SLCO4A1—adipose tissue—breast cancer	0.00041	0.0107	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—breast cancer	0.000408	0.0107	CbGeAlD
Levothyroxine—SLCO1C1—endocrine gland—breast cancer	0.000398	0.0104	CbGeAlD
Levothyroxine—TTR—bone marrow—breast cancer	0.000397	0.0104	CbGeAlD
Levothyroxine—SLC7A5—female gonad—breast cancer	0.000393	0.0103	CbGeAlD
Levothyroxine—SLCO4A1—female reproductive system—breast cancer	0.000377	0.00988	CbGeAlD
Levothyroxine—SLCO4A1—adrenal gland—breast cancer	0.000368	0.00964	CbGeAlD
Levothyroxine—SLC7A5—endocrine gland—breast cancer	0.000366	0.00957	CbGeAlD
Levothyroxine—TTR—endocrine gland—breast cancer	0.000356	0.00933	CbGeAlD
Levothyroxine—SLCO1B1—female reproductive system—breast cancer	0.000332	0.00869	CbGeAlD
Levothyroxine—THRB—lymph node—breast cancer	0.000331	0.00868	CbGeAlD
Levothyroxine—THRA—lymph node—breast cancer	0.000331	0.00868	CbGeAlD
Levothyroxine—SLCO4A1—endocrine gland—breast cancer	0.000319	0.00836	CbGeAlD
Levothyroxine—Liothyronine—SLCO1B1—breast cancer	0.000303	0.0813	CrCbGaD
Levothyroxine—SLC16A2—lymph node—breast cancer	0.0003	0.00786	CbGeAlD
Levothyroxine—SLCO1B1—endocrine gland—breast cancer	0.000281	0.00736	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—breast cancer	0.000275	0.00721	CbGeAlD
Levothyroxine—ALB—adrenal gland—breast cancer	0.000262	0.00686	CbGeAlD
Levothyroxine—SLC7A5—lymph node—breast cancer	0.000253	0.00662	CbGeAlD
Levothyroxine—SLCO1A2—endocrine gland—breast cancer	0.000229	0.00599	CbGeAlD
Levothyroxine—CYP2C8—endometrium—breast cancer	0.000228	0.00597	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—breast cancer	0.000221	0.00578	CbGeAlD
Levothyroxine—CYP2C8—pituitary gland—breast cancer	0.000206	0.0054	CbGeAlD
Levothyroxine—CYP2C8—female reproductive system—breast cancer	0.000189	0.00494	CbGeAlD
Levothyroxine—CYP2C8—endocrine gland—breast cancer	0.00016	0.00418	CbGeAlD
Levothyroxine—ALB—lymph node—breast cancer	0.000157	0.00411	CbGeAlD
Levothyroxine—ABCB1—embryo—breast cancer	0.000149	0.00391	CbGeAlD
Levothyroxine—CYP3A4—female reproductive system—breast cancer	0.000128	0.00335	CbGeAlD
Levothyroxine—ABCB1—epithelium—breast cancer	0.000122	0.00319	CbGeAlD
Levothyroxine—ABCB1—endometrium—breast cancer	0.000109	0.00286	CbGeAlD
Levothyroxine—CYP3A4—endocrine gland—breast cancer	0.000108	0.00283	CbGeAlD
Levothyroxine—ABCB1—uterus—breast cancer	0.000101	0.00264	CbGeAlD
Levothyroxine—ABCB1—pituitary gland—breast cancer	9.89e-05	0.00259	CbGeAlD
Levothyroxine—ABCB1—adipose tissue—breast cancer	9.85e-05	0.00258	CbGeAlD
Levothyroxine—ABCB1—female reproductive system—breast cancer	9.05e-05	0.00237	CbGeAlD
Levothyroxine—ABCB1—adrenal gland—breast cancer	8.83e-05	0.00231	CbGeAlD
Levothyroxine—ABCB1—bone marrow—breast cancer	8.54e-05	0.00224	CbGeAlD
Levothyroxine—ABCB1—female gonad—breast cancer	8.23e-05	0.00216	CbGeAlD
Levothyroxine—Liotrix—ALB—breast cancer	7.89e-05	0.0211	CrCbGaD
Levothyroxine—ABCB1—endocrine gland—breast cancer	7.66e-05	0.00201	CbGeAlD
Levothyroxine—Liotrix—ABCB1—breast cancer	7.53e-05	0.0202	CrCbGaD
Levothyroxine—Flushing—Capecitabine—breast cancer	6.58e-05	0.000749	CcSEcCtD
Levothyroxine—Dermatitis—Melphalan—breast cancer	6.58e-05	0.000749	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—breast cancer	6.57e-05	0.000747	CcSEcCtD
Levothyroxine—Asthenia—Vinorelbine—breast cancer	6.55e-05	0.000745	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—breast cancer	6.54e-05	0.000744	CcSEcCtD
Levothyroxine—Dyspnoea—Gemcitabine—breast cancer	6.54e-05	0.000744	CcSEcCtD
Levothyroxine—Nausea—Vinblastine—breast cancer	6.53e-05	0.000742	CcSEcCtD
Levothyroxine—Insomnia—Fluorouracil—breast cancer	6.52e-05	0.000742	CcSEcCtD
Levothyroxine—Convulsion—Paclitaxel—breast cancer	6.52e-05	0.000741	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—breast cancer	6.51e-05	0.00074	CcSEcCtD
Levothyroxine—Fatigue—Irinotecan—breast cancer	6.49e-05	0.000738	CcSEcCtD
Levothyroxine—Fatigue—Mitoxantrone—breast cancer	6.49e-05	0.000738	CcSEcCtD
Levothyroxine—Vomiting—Goserelin—breast cancer	6.48e-05	0.000737	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—breast cancer	6.47e-05	0.000736	CcSEcCtD
Levothyroxine—Pruritus—Vinorelbine—breast cancer	6.46e-05	0.000735	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—breast cancer	6.43e-05	0.000731	CcSEcCtD
Levothyroxine—Rash—Goserelin—breast cancer	6.43e-05	0.000731	CcSEcCtD
Levothyroxine—Dermatitis—Goserelin—breast cancer	6.42e-05	0.00073	CcSEcCtD
Levothyroxine—Arthralgia—Paclitaxel—breast cancer	6.41e-05	0.000728	CcSEcCtD
Levothyroxine—Headache—Goserelin—breast cancer	6.39e-05	0.000726	CcSEcCtD
Levothyroxine—Anxiety—Paclitaxel—breast cancer	6.38e-05	0.000726	CcSEcCtD
Levothyroxine—Nausea—Tamoxifen—breast cancer	6.34e-05	0.000721	CcSEcCtD
Levothyroxine—Arrhythmia—Capecitabine—breast cancer	6.34e-05	0.000721	CcSEcCtD
Levothyroxine—Fatigue—Gemcitabine—breast cancer	6.32e-05	0.000719	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—breast cancer	6.3e-05	0.000716	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—breast cancer	6.28e-05	0.000715	CcSEcCtD
Levothyroxine—Alopecia—Capecitabine—breast cancer	6.27e-05	0.000713	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—breast cancer	6.26e-05	0.000712	CcSEcCtD
Levothyroxine—Asthenia—Thiotepa—breast cancer	6.26e-05	0.000711	CcSEcCtD
Levothyroxine—Diarrhoea—Vinorelbine—breast cancer	6.25e-05	0.00071	CcSEcCtD
Levothyroxine—Nausea—Melphalan—breast cancer	6.21e-05	0.000706	CcSEcCtD
Levothyroxine—Feeling abnormal—Mitoxantrone—breast cancer	6.2e-05	0.000706	CcSEcCtD
Levothyroxine—Feeling abnormal—Irinotecan—breast cancer	6.2e-05	0.000706	CcSEcCtD
Levothyroxine—Confusional state—Paclitaxel—breast cancer	6.19e-05	0.000704	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—breast cancer	6.17e-05	0.000702	CcSEcCtD
Levothyroxine—Pruritus—Thiotepa—breast cancer	6.17e-05	0.000701	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mitoxantrone—breast cancer	6.16e-05	0.0007	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Irinotecan—breast cancer	6.16e-05	0.0007	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—breast cancer	6.15e-05	0.000699	CcSEcCtD
Levothyroxine—Nausea—Goserelin—breast cancer	6.05e-05	0.000689	CcSEcCtD
Levothyroxine—Feeling abnormal—Gemcitabine—breast cancer	6.04e-05	0.000687	CcSEcCtD
Levothyroxine—Shock—Paclitaxel—breast cancer	6.04e-05	0.000687	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—breast cancer	6.01e-05	0.000684	CcSEcCtD
Levothyroxine—Tachycardia—Paclitaxel—breast cancer	5.99e-05	0.000682	CcSEcCtD
Levothyroxine—Urticaria—Mitoxantrone—breast cancer	5.98e-05	0.00068	CcSEcCtD
Levothyroxine—Diarrhoea—Thiotepa—breast cancer	5.97e-05	0.000678	CcSEcCtD
Levothyroxine—Abdominal pain—Mitoxantrone—breast cancer	5.95e-05	0.000677	CcSEcCtD
Levothyroxine—Abdominal pain—Irinotecan—breast cancer	5.95e-05	0.000677	CcSEcCtD
Levothyroxine—Body temperature increased—Mitoxantrone—breast cancer	5.95e-05	0.000677	CcSEcCtD
Levothyroxine—Body temperature increased—Irinotecan—breast cancer	5.95e-05	0.000677	CcSEcCtD
Levothyroxine—Feeling abnormal—Fluorouracil—breast cancer	5.94e-05	0.000676	CcSEcCtD
Levothyroxine—Hyperhidrosis—Paclitaxel—breast cancer	5.94e-05	0.000675	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—breast cancer	5.83e-05	0.000663	CcSEcCtD
Levothyroxine—Vomiting—Vinorelbine—breast cancer	5.8e-05	0.00066	CcSEcCtD
Levothyroxine—Body temperature increased—Gemcitabine—breast cancer	5.8e-05	0.000659	CcSEcCtD
Levothyroxine—Tremor—Capecitabine—breast cancer	5.78e-05	0.000658	CcSEcCtD
Levothyroxine—Liothyronine—ALB—breast cancer	5.76e-05	0.0154	CrCbGaD
Levothyroxine—Rash—Vinorelbine—breast cancer	5.76e-05	0.000655	CcSEcCtD
Levothyroxine—Dermatitis—Vinorelbine—breast cancer	5.75e-05	0.000654	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—breast cancer	5.73e-05	0.000651	CcSEcCtD
Levothyroxine—Headache—Vinorelbine—breast cancer	5.72e-05	0.00065	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—breast cancer	5.71e-05	0.00065	CcSEcCtD
Levothyroxine—Body temperature increased—Fluorouracil—breast cancer	5.7e-05	0.000648	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—breast cancer	5.64e-05	0.000641	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—breast cancer	5.64e-05	0.000641	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Paclitaxel—breast cancer	5.59e-05	0.000636	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—breast cancer	5.59e-05	0.000635	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—breast cancer	5.56e-05	0.000633	CcSEcCtD
Levothyroxine—Insomnia—Paclitaxel—breast cancer	5.55e-05	0.000632	CcSEcCtD
Levothyroxine—Vomiting—Thiotepa—breast cancer	5.54e-05	0.00063	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—breast cancer	5.53e-05	0.000628	CcSEcCtD
Levothyroxine—Rash—Thiotepa—breast cancer	5.5e-05	0.000625	CcSEcCtD
Levothyroxine—Liothyronine—ABCB1—breast cancer	5.5e-05	0.0147	CrCbGaD
Levothyroxine—Dermatitis—Thiotepa—breast cancer	5.49e-05	0.000625	CcSEcCtD
Levothyroxine—Dyspnoea—Paclitaxel—breast cancer	5.47e-05	0.000623	CcSEcCtD
Levothyroxine—Headache—Thiotepa—breast cancer	5.46e-05	0.000621	CcSEcCtD
Levothyroxine—Palpitations—Capecitabine—breast cancer	5.46e-05	0.00062	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—breast cancer	5.43e-05	0.000617	CcSEcCtD
Levothyroxine—Nausea—Vinorelbine—breast cancer	5.42e-05	0.000617	CcSEcCtD
Levothyroxine—Asthenia—Mitoxantrone—breast cancer	5.4e-05	0.000614	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—breast cancer	5.4e-05	0.000614	CcSEcCtD
Levothyroxine—Fatigue—Paclitaxel—breast cancer	5.29e-05	0.000602	CcSEcCtD
Levothyroxine—ABCB1—lymph node—breast cancer	5.29e-05	0.00139	CbGeAlD
Levothyroxine—Sweating—Epirubicin—breast cancer	5.28e-05	0.0006	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—breast cancer	5.26e-05	0.000598	CcSEcCtD
Levothyroxine—Arthralgia—Capecitabine—breast cancer	5.26e-05	0.000598	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—breast cancer	5.25e-05	0.000597	CcSEcCtD
Levothyroxine—Anxiety—Capecitabine—breast cancer	5.24e-05	0.000596	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—breast cancer	5.19e-05	0.00059	CcSEcCtD
Levothyroxine—Nausea—Thiotepa—breast cancer	5.18e-05	0.000589	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—breast cancer	5.17e-05	0.000588	CcSEcCtD
Levothyroxine—Diarrhoea—Irinotecan—breast cancer	5.15e-05	0.000586	CcSEcCtD
Levothyroxine—Diarrhoea—Mitoxantrone—breast cancer	5.15e-05	0.000586	CcSEcCtD
Levothyroxine—Shock—Docetaxel—breast cancer	5.12e-05	0.000582	CcSEcCtD
Levothyroxine—Pruritus—Fluorouracil—breast cancer	5.1e-05	0.00058	CcSEcCtD
Levothyroxine—Confusional state—Capecitabine—breast cancer	5.08e-05	0.000578	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—breast cancer	5.08e-05	0.000578	CcSEcCtD
Levothyroxine—Feeling abnormal—Paclitaxel—breast cancer	5.06e-05	0.000575	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Paclitaxel—breast cancer	5.02e-05	0.000571	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—breast cancer	5.02e-05	0.000571	CcSEcCtD
Levothyroxine—Shock—Capecitabine—breast cancer	4.96e-05	0.000564	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—breast cancer	4.93e-05	0.000561	CcSEcCtD
Levothyroxine—Tachycardia—Capecitabine—breast cancer	4.92e-05	0.000559	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—breast cancer	4.88e-05	0.000555	CcSEcCtD
Levothyroxine—Urticaria—Paclitaxel—breast cancer	4.88e-05	0.000555	CcSEcCtD
Levothyroxine—Hyperhidrosis—Capecitabine—breast cancer	4.87e-05	0.000554	CcSEcCtD
Levothyroxine—Body temperature increased—Paclitaxel—breast cancer	4.85e-05	0.000552	CcSEcCtD
Levothyroxine—Abdominal pain—Paclitaxel—breast cancer	4.85e-05	0.000552	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—breast cancer	4.79e-05	0.000544	CcSEcCtD
Levothyroxine—Vomiting—Mitoxantrone—breast cancer	4.79e-05	0.000544	CcSEcCtD
Levothyroxine—Rash—Mitoxantrone—breast cancer	4.75e-05	0.00054	CcSEcCtD
Levothyroxine—Rash—Irinotecan—breast cancer	4.75e-05	0.00054	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—breast cancer	4.74e-05	0.000539	CcSEcCtD
Levothyroxine—Dermatitis—Mitoxantrone—breast cancer	4.74e-05	0.000539	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.74e-05	0.000539	CcSEcCtD
Levothyroxine—Headache—Irinotecan—breast cancer	4.72e-05	0.000536	CcSEcCtD
Levothyroxine—Headache—Mitoxantrone—breast cancer	4.72e-05	0.000536	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—breast cancer	4.71e-05	0.000535	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—breast cancer	4.67e-05	0.000531	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—breast cancer	4.66e-05	0.00053	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—breast cancer	4.64e-05	0.000528	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—breast cancer	4.62e-05	0.000526	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—breast cancer	4.62e-05	0.000525	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—breast cancer	4.59e-05	0.000522	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.59e-05	0.000522	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—breast cancer	4.59e-05	0.000522	CcSEcCtD
Levothyroxine—Vomiting—Fluorouracil—breast cancer	4.59e-05	0.000521	CcSEcCtD
Levothyroxine—Insomnia—Capecitabine—breast cancer	4.56e-05	0.000518	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—breast cancer	4.55e-05	0.000517	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—breast cancer	4.54e-05	0.000517	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—breast cancer	4.52e-05	0.000514	CcSEcCtD
Levothyroxine—Dyspnoea—Capecitabine—breast cancer	4.49e-05	0.000511	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—breast cancer	4.49e-05	0.00051	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—breast cancer	4.47e-05	0.000509	CcSEcCtD
Levothyroxine—Nausea—Mitoxantrone—breast cancer	4.47e-05	0.000509	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—breast cancer	4.41e-05	0.000502	CcSEcCtD
Levothyroxine—Asthenia—Paclitaxel—breast cancer	4.41e-05	0.000501	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—breast cancer	4.37e-05	0.000497	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—breast cancer	4.36e-05	0.000495	CcSEcCtD
Levothyroxine—Fatigue—Capecitabine—breast cancer	4.34e-05	0.000494	CcSEcCtD
Levothyroxine—Pruritus—Paclitaxel—breast cancer	4.34e-05	0.000494	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—breast cancer	4.29e-05	0.000488	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—breast cancer	4.28e-05	0.000487	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—breast cancer	4.26e-05	0.000484	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—breast cancer	4.24e-05	0.000483	CcSEcCtD
Levothyroxine—Tension—Epirubicin—breast cancer	4.22e-05	0.00048	CcSEcCtD
Levothyroxine—Diarrhoea—Paclitaxel—breast cancer	4.2e-05	0.000478	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—breast cancer	4.18e-05	0.000475	CcSEcCtD
Levothyroxine—Feeling abnormal—Capecitabine—breast cancer	4.15e-05	0.000472	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Capecitabine—breast cancer	4.12e-05	0.000469	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—breast cancer	4.11e-05	0.000468	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—breast cancer	4.11e-05	0.000468	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—breast cancer	4.08e-05	0.000464	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—breast cancer	4.04e-05	0.000459	CcSEcCtD
Levothyroxine—Urticaria—Capecitabine—breast cancer	4e-05	0.000455	CcSEcCtD
Levothyroxine—Abdominal pain—Capecitabine—breast cancer	3.98e-05	0.000453	CcSEcCtD
Levothyroxine—Body temperature increased—Capecitabine—breast cancer	3.98e-05	0.000453	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—breast cancer	3.98e-05	0.000453	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—breast cancer	3.95e-05	0.00045	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—breast cancer	3.91e-05	0.000445	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—breast cancer	3.91e-05	0.000444	CcSEcCtD
Levothyroxine—Vomiting—Paclitaxel—breast cancer	3.9e-05	0.000444	CcSEcCtD
Levothyroxine—Rash—Paclitaxel—breast cancer	3.87e-05	0.00044	CcSEcCtD
Levothyroxine—Dermatitis—Paclitaxel—breast cancer	3.87e-05	0.00044	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—breast cancer	3.87e-05	0.00044	CcSEcCtD
Levothyroxine—Headache—Paclitaxel—breast cancer	3.85e-05	0.000437	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—breast cancer	3.8e-05	0.000432	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—breast cancer	3.78e-05	0.00043	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—breast cancer	3.73e-05	0.000425	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—breast cancer	3.73e-05	0.000424	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—breast cancer	3.68e-05	0.000419	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—breast cancer	3.66e-05	0.000416	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—breast cancer	3.66e-05	0.000416	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—breast cancer	3.65e-05	0.000415	CcSEcCtD
Levothyroxine—Nausea—Paclitaxel—breast cancer	3.65e-05	0.000415	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—breast cancer	3.63e-05	0.000412	CcSEcCtD
Levothyroxine—Asthenia—Capecitabine—breast cancer	3.62e-05	0.000411	CcSEcCtD
Levothyroxine—Pruritus—Capecitabine—breast cancer	3.57e-05	0.000405	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—breast cancer	3.56e-05	0.000405	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—breast cancer	3.54e-05	0.000403	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—breast cancer	3.52e-05	0.0004	CcSEcCtD
Levothyroxine—Shock—Epirubicin—breast cancer	3.45e-05	0.000393	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—breast cancer	3.45e-05	0.000392	CcSEcCtD
Levothyroxine—Diarrhoea—Capecitabine—breast cancer	3.45e-05	0.000392	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—breast cancer	3.43e-05	0.00039	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.42e-05	0.000389	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—breast cancer	3.39e-05	0.000386	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—breast cancer	3.39e-05	0.000386	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—breast cancer	3.39e-05	0.000385	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—breast cancer	3.38e-05	0.000384	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—breast cancer	3.34e-05	0.00038	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—breast cancer	3.31e-05	0.000376	CcSEcCtD
Levothyroxine—Rash—Docetaxel—breast cancer	3.28e-05	0.000373	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—breast cancer	3.28e-05	0.000373	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—breast cancer	3.28e-05	0.000372	CcSEcCtD
Levothyroxine—Headache—Docetaxel—breast cancer	3.26e-05	0.000371	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—breast cancer	3.23e-05	0.000368	CcSEcCtD
Levothyroxine—Vomiting—Capecitabine—breast cancer	3.2e-05	0.000364	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.2e-05	0.000364	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—breast cancer	3.2e-05	0.000363	CcSEcCtD
Levothyroxine—Rash—Capecitabine—breast cancer	3.18e-05	0.000361	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—breast cancer	3.18e-05	0.000361	CcSEcCtD
Levothyroxine—Dermatitis—Capecitabine—breast cancer	3.17e-05	0.000361	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—breast cancer	3.17e-05	0.000361	CcSEcCtD
Levothyroxine—Headache—Capecitabine—breast cancer	3.16e-05	0.000359	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—breast cancer	3.14e-05	0.000357	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—breast cancer	3.13e-05	0.000356	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—breast cancer	3.09e-05	0.000352	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—breast cancer	3.09e-05	0.000352	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—breast cancer	3.07e-05	0.000349	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—breast cancer	3.03e-05	0.000344	CcSEcCtD
Levothyroxine—Nausea—Capecitabine—breast cancer	2.99e-05	0.00034	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—breast cancer	2.98e-05	0.000339	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—breast cancer	2.97e-05	0.000337	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—breast cancer	2.97e-05	0.000337	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.96e-05	0.000337	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—breast cancer	2.94e-05	0.000334	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—breast cancer	2.9e-05	0.000329	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—breast cancer	2.89e-05	0.000329	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—breast cancer	2.87e-05	0.000326	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—breast cancer	2.8e-05	0.000318	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—breast cancer	2.79e-05	0.000317	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—breast cancer	2.78e-05	0.000316	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—breast cancer	2.78e-05	0.000316	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—breast cancer	2.69e-05	0.000306	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—breast cancer	2.68e-05	0.000304	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—breast cancer	2.66e-05	0.000302	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—breast cancer	2.65e-05	0.000302	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—breast cancer	2.58e-05	0.000293	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—breast cancer	2.57e-05	0.000292	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—breast cancer	2.57e-05	0.000292	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—breast cancer	2.57e-05	0.000292	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—breast cancer	2.52e-05	0.000286	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—breast cancer	2.48e-05	0.000282	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—breast cancer	2.4e-05	0.000273	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—breast cancer	2.39e-05	0.000271	CcSEcCtD
Levothyroxine—Rash—Methotrexate—breast cancer	2.37e-05	0.000269	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—breast cancer	2.36e-05	0.000269	CcSEcCtD
Levothyroxine—Headache—Methotrexate—breast cancer	2.35e-05	0.000267	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—breast cancer	2.33e-05	0.000265	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—breast cancer	2.3e-05	0.000261	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—breast cancer	2.23e-05	0.000254	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—breast cancer	2.23e-05	0.000253	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—breast cancer	2.22e-05	0.000253	CcSEcCtD
Levothyroxine—Rash—Epirubicin—breast cancer	2.21e-05	0.000252	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—breast cancer	2.21e-05	0.000251	CcSEcCtD
Levothyroxine—Headache—Epirubicin—breast cancer	2.2e-05	0.00025	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—breast cancer	2.09e-05	0.000237	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—breast cancer	2.07e-05	0.000235	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—breast cancer	2.05e-05	0.000233	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—breast cancer	2.05e-05	0.000233	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—breast cancer	2.03e-05	0.000231	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—breast cancer	1.93e-05	0.000219	CcSEcCtD
Levothyroxine—ALB—Metabolism—PTGS1—breast cancer	2.19e-06	2.63e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—breast cancer	2.19e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.18e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.17e-06	2.6e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2D6—breast cancer	2.16e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CPT1A—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCG2—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTR—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2D6—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAF1—breast cancer	2.14e-06	2.57e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—breast cancer	2.14e-06	2.57e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—breast cancer	2.14e-06	2.56e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAV1—breast cancer	2.13e-06	2.55e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA2—breast cancer	2.12e-06	2.54e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—breast cancer	2.12e-06	2.54e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPGDS—breast cancer	2.11e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA2—breast cancer	2.11e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HBA1—breast cancer	2.1e-06	2.52e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—breast cancer	2.09e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—breast cancer	2.09e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NME1—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FHL2—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PHGDH—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UMPS—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ADSL—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—FASN—breast cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ACHE—breast cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—breast cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BCHE—breast cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—FASN—breast cancer	2.05e-06	2.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BCHE—breast cancer	2.04e-06	2.44e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.03e-06	2.43e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—breast cancer	2.02e-06	2.43e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BRIP1—breast cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPSE—breast cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LDHB—breast cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—breast cancer	2.01e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—breast cancer	1.99e-06	2.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.99e-06	2.38e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—breast cancer	1.98e-06	2.37e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—breast cancer	1.97e-06	2.35e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC2A1—breast cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NQO1—breast cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC2A1—breast cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NQO1—breast cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP17A1—breast cancer	1.94e-06	2.32e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.94e-06	2.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO1—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS1—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMMR—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA3—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCC1—breast cancer	1.92e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.91e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—breast cancer	1.91e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP3A4—breast cancer	1.91e-06	2.28e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.9e-06	2.28e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.9e-06	2.27e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP3A4—breast cancer	1.9e-06	2.27e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.89e-06	2.26e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2D6—breast cancer	1.88e-06	2.26e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—breast cancer	1.88e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1B1—breast cancer	1.87e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1B1—breast cancer	1.86e-06	2.23e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.86e-06	2.22e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.85e-06	2.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA2—breast cancer	1.85e-06	2.22e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HSP90AA1—breast cancer	1.84e-06	2.2e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HSP90AA1—breast cancer	1.83e-06	2.19e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—breast cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.8e-06	2.15e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—FASN—breast cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA1—breast cancer	1.79e-06	2.14e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BCHE—breast cancer	1.79e-06	2.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA1—breast cancer	1.78e-06	2.13e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—breast cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—STK11—breast cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP19A1—breast cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—breast cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—STK11—breast cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP19A1—breast cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA4—breast cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA9—breast cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.74e-06	2.08e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—breast cancer	1.72e-06	2.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX2—breast cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA2—breast cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC2A1—breast cancer	1.7e-06	2.04e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NQO1—breast cancer	1.7e-06	2.04e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.7e-06	2.04e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX4—breast cancer	1.69e-06	2.02e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SULT1A1—breast cancer	1.69e-06	2.02e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—breast cancer	1.68e-06	2.02e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—breast cancer	1.68e-06	2.01e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—breast cancer	1.68e-06	2.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP3A4—breast cancer	1.66e-06	1.99e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.65e-06	1.98e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA1—breast cancer	1.65e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—IDH1—breast cancer	1.65e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.65e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—COMT—breast cancer	1.64e-06	1.96e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1B1—breast cancer	1.63e-06	1.96e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—breast cancer	1.63e-06	1.96e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—breast cancer	1.63e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—COMT—breast cancer	1.63e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NAT2—breast cancer	1.63e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.62e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—breast cancer	1.62e-06	1.94e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—breast cancer	1.61e-06	1.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HMOX1—breast cancer	1.61e-06	1.93e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—breast cancer	1.61e-06	1.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ITPR1—breast cancer	1.6e-06	1.92e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HSP90AA1—breast cancer	1.6e-06	1.92e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HMOX1—breast cancer	1.6e-06	1.92e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ITPR1—breast cancer	1.6e-06	1.91e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA1—breast cancer	1.56e-06	1.87e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—breast cancer	1.54e-06	1.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—breast cancer	1.54e-06	1.85e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—STK11—breast cancer	1.54e-06	1.84e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP19A1—breast cancer	1.54e-06	1.84e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—breast cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—breast cancer	1.52e-06	1.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—breast cancer	1.51e-06	1.81e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—breast cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOR1—breast cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—breast cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—breast cancer	1.5e-06	1.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PLA2G4A—breast cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOR1—breast cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—breast cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—breast cancer	1.49e-06	1.78e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.48e-06	1.78e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—breast cancer	1.47e-06	1.76e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPX1—breast cancer	1.44e-06	1.72e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MED12—breast cancer	1.43e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DPYD—breast cancer	1.43e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—COMT—breast cancer	1.43e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPX1—breast cancer	1.43e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—breast cancer	1.42e-06	1.7e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A1—breast cancer	1.42e-06	1.7e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A1—breast cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—breast cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDOA—breast cancer	1.41e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HMOX1—breast cancer	1.4e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—breast cancer	1.4e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ITPR1—breast cancer	1.4e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—breast cancer	1.39e-06	1.66e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA3—breast cancer	1.36e-06	1.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC2A2—breast cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—breast cancer	1.35e-06	1.61e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTR—breast cancer	1.33e-06	1.59e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG2—breast cancer	1.33e-06	1.59e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CPT1A—breast cancer	1.33e-06	1.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—breast cancer	1.32e-06	1.59e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—breast cancer	1.32e-06	1.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—breast cancer	1.32e-06	1.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—breast cancer	1.31e-06	1.56e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOR1—breast cancer	1.31e-06	1.56e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PLA2G4A—breast cancer	1.31e-06	1.56e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPGDS—breast cancer	1.3e-06	1.56e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HBA1—breast cancer	1.29e-06	1.55e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—breast cancer	1.28e-06	1.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—breast cancer	1.27e-06	1.53e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACHE—breast cancer	1.26e-06	1.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—breast cancer	1.26e-06	1.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPX1—breast cancer	1.25e-06	1.5e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A1—breast cancer	1.24e-06	1.48e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—breast cancer	1.23e-06	1.48e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—breast cancer	1.23e-06	1.47e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAV1—breast cancer	1.22e-06	1.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAV1—breast cancer	1.21e-06	1.46e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.2e-06	1.43e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO1—breast cancer	1.18e-06	1.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS1—breast cancer	1.18e-06	1.42e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—breast cancer	1.18e-06	1.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.17e-06	1.4e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.16e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.16e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—breast cancer	1.15e-06	1.38e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA2—breast cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—breast cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—breast cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FASN—breast cancer	1.1e-06	1.32e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BCHE—breast cancer	1.1e-06	1.32e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—breast cancer	1.1e-06	1.32e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.09e-06	1.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAV1—breast cancer	1.06e-06	1.28e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—breast cancer	1.06e-06	1.27e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NQO1—breast cancer	1.05e-06	1.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.05e-06	1.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—breast cancer	1.04e-06	1.25e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.01e-06	1.21e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.87e-07	1.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—breast cancer	9.78e-07	1.17e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—breast cancer	9.73e-07	1.17e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—breast cancer	9.69e-07	1.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—breast cancer	9.66e-07	1.16e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA1—breast cancer	9.6e-07	1.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—STK11—breast cancer	9.46e-07	1.13e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP19A1—breast cancer	9.46e-07	1.13e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—breast cancer	9.24e-07	1.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—breast cancer	9.18e-07	1.1e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—breast cancer	9.05e-07	1.08e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—COMT—breast cancer	8.79e-07	1.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—breast cancer	8.75e-07	1.05e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—breast cancer	8.64e-07	1.04e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMOX1—breast cancer	8.63e-07	1.03e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ITPR1—breast cancer	8.61e-07	1.03e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—breast cancer	8.53e-07	1.02e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—breast cancer	8.52e-07	1.02e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—breast cancer	8.48e-07	1.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—breast cancer	8.45e-07	1.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—breast cancer	8.41e-07	1.01e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—breast cancer	8.4e-07	1.01e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—breast cancer	8.29e-07	9.93e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—breast cancer	8.14e-07	9.75e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—breast cancer	8.05e-07	9.64e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.04e-07	9.64e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—breast cancer	8.04e-07	9.64e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOR1—breast cancer	8.04e-07	9.64e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX1—breast cancer	7.7e-07	9.23e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A1—breast cancer	7.63e-07	9.14e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—breast cancer	7.56e-07	9.06e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—breast cancer	7.43e-07	8.9e-06	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—breast cancer	7.39e-07	8.85e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—breast cancer	7.37e-07	8.83e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—breast cancer	7.36e-07	8.82e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—breast cancer	7.33e-07	8.78e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—breast cancer	7.11e-07	8.52e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAV1—breast cancer	6.56e-07	7.86e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—breast cancer	6.42e-07	7.69e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—breast cancer	5.97e-07	7.16e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—breast cancer	5.25e-07	6.29e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—breast cancer	5.2e-07	6.23e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—breast cancer	5.18e-07	6.21e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—breast cancer	5.17e-07	6.19e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—breast cancer	4.96e-07	5.94e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—breast cancer	4.58e-07	5.48e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—breast cancer	4.53e-07	5.43e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—breast cancer	4.53e-07	5.43e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—breast cancer	4.25e-07	5.09e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—breast cancer	4.22e-07	5.06e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—breast cancer	3.95e-07	4.74e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—breast cancer	3.7e-07	4.43e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.79e-07	3.34e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—breast cancer	2.28e-07	2.73e-06	CbGpPWpGaD
